Skip to content

Apotheek De Bal

Active
Private limited companyfounded 2021active for 5 yearsGen. Lemanstraat 40, 8930 Menen, BelgiumKBO/BCE: BE 0775.842.325
Summary

Apotheek De Bal has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €177,033 and a net result of €112,189. Equity has been shrinking by about 9% per year since 2021. Its solvency ranks better than 36% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Overview

Official details

Source: KBO
Status
Active since 06-10-2021 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.324.654.983 8930 Menen, since 06-10-2021
Financial year end
31 December
Peppol
Reachable since 06-11-2025

Board and ownership

Board
  • THE TRIPLE A COMPANY VOFDirector
  • Vereenooghe CharlotteDirector

Financial position

87 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.3%
Annual accounts 2025
Gross margin
€307,066
▼ 17.0%
Turnover
≈ €1.1m
estimated
Profit
€112,189
▼ 15.6%
Equity
€177,033
▼ 10.5%
Total assets
€719,624
▲ 8.1%
Employees on 31-12-2025
3
=
Score breakdownraises riskFounded in 2021lowers riskLiquidity: current ratio 2.02, cash €207,632Figures for financial year 2025 (filed on 17-04-2026)Size: 1.7 FTE, total assets €719,624Show the evidence

Checked score

Score 2025
87 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 55% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 50-5
equity 24.6% of total assets
Liquidity 64+7
short-term debt 44.9% · cash 28.9%
Profitability 88-6
return on assets 15.6%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.4% 01-2025: 0.4%● unchanged vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025 08-2025: 0.4%● unchanged vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.5%▲ +0.1 percentage points vs 02-2026 04-2026: 0.5%● unchanged vs 03-2026highest value 05-2026: 0.3%▼ -0.2 percentage points vs 04-2026lowest value 06-2026: 0.3%● unchanged vs 05-2026lowest value 07-2026: 0.3%● unchanged vs 06-2026lowest value 08-2026: 0.3%● unchanged vs 07-2026lowest value 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026 11-2026: 0.3%● unchanged vs 10-2026
Credit of up to €15,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.02 (2.53 in 2024), above the usual 1.5. Short-term debt is 44.9% and cash 28.9% of total assets. However, 75.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 40% of them on solvency, 71% on liquidity, 83% on profitability and 26% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 2.02, cash €207,632
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 17-04-2026)
NBB · annual accounts
raises risk · Founded in 2021
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Size: 1.7 FTE, total assets €719,624
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 17-04-2026, 105 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
105 days early
2024
42 days early
2023
65 days early
2022
18 days early
2021
8 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 44 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 19 June (4 of the last 5 accounts filed within 50 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 5 profitable years in a rowprofit 2025: €112,189 5 years View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

Recent changes

  1. · Gazette deed Incorporation
All 7 events

Comparable companies

These companies have the same main activity as Apotheek De Bal: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €605,000 and €866,000, founded between 2020 and 2023.

CompanyTotal assetsGross margin
Apotheek De Bal Menen€719,624€307,066
APOTHEEK PANORAMA HOUTHALEN Houthalen-Helchteren€784,477€311,792
APOTHEEK HECHTEL Hechtel-Eksel€808,225€323,319
PHARMACIE DELDICQUE-LENFANT SRL Tournai€785,310€244,060
Pharmacie BORN Flémalle€605,474€290,523
PHARMACIE DU THIER-A-LIEGE Liège€865,604€307,596
APOTHEEK SCHORVOORT Turnhout€818,347€253,621
Full comparison

Key facts about Apotheek De Bal

What is the company number of Apotheek De Bal?
The company number of Apotheek De Bal is 0775.842.325. The VAT number is the same number with BE in front: BE 0775.842.325.
Where is Apotheek De Bal based?
The registered office is at Gen. Lemanstraat 40, 8930 Menen.Company details
What does Apotheek De Bal do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek De Bal?
The legal form of Apotheek De Bal is Private limited company (BV).
When was Apotheek De Bal founded?
Apotheek De Bal was founded on 06-10-2021.
Is Apotheek De Bal still active?
Yes, Apotheek De Bal is an active enterprise in the KBO register.
How many employees does Apotheek De Bal have?
Apotheek De Bal had an average of 1.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Apotheek De Bal fall under?
In its 2025 annual accounts, Apotheek De Bal states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of Apotheek De Bal?
The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €307,066 and 47 comparable companies (NACE 477). It probably lies between €870,000 and €1.8m.
Is Apotheek De Bal profitable?
In financial year 2025, Apotheek De Bal made a profit of €112,189.
Where can I find the annual accounts of Apotheek De Bal?
Apotheek De Bal filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek De Bal due?
Apotheek De Bal must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.